Cite

HARVARD Citation

    Coates, L. et al. (n.d.). SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study. Annals of the rheumatic diseases. pp. 948-949. [Online]. 
  
Back to record